The Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia.

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
TitleThe Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia.
Publication TypeJournal Article
Year of Publication2018
AuthorsWinkler, TE, Stevenson, FO, Kim, E, Kang, M, Payne, GF, Kelly, DL, Ghodssi, R
JournalIEEE Sens Lett
Volume2
Issue1
Date Published2018 Mar
ISSN2475-1472
Abstract

We present a perspective on microsystems integration aspects for concurrent cellular and molecular sensing in a lab-on-a-chip device. While of interest for a range of applications, very few - narrowly focused - examples of such devices can be found in the literature. Here, we approach the challenge from a systems level, considering sensor integration both in parallel and in series. Our study is specifically geared toward schizophrenia treatment, where concurrent blood monitoring of the antipsychotic clozapine and white blood cells could lead to improved treatment outcomes. We evaluate the critical system components for either design, namely plasma skimming (parallel) and in-blood clozapine detection (series). We find that plasma skimming is infeasible, but for the first time demonstrate direct detection of clozapine in whole blood. With a corresponding series-integrated microsystem, we finally demonstrate downstream white blood cell analysis on the same samples using impedance cytometry. We thus present the first lab-on-a-chip device capable of label- and reagent-free concurrent sensing of cellular and molecular markers.

DOI10.1109/LSENS.2017.2782883
Alternate JournalIEEE Sens Lett
PubMed ID29308452
PubMed Central IDPMC5754032
Grant ListR56 MH105571 / MH / NIMH NIH HHS / United States